Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Access to healthcare

Brazil court strips Gilead hepatitis drug patent, politician says

Editor's pick
Reuters
25 September 2018
Hepatitis C treatment

Overwhelming evidence shows hepatitis C treatment effective for people who inject drugs

Editor's pick
EurekAlert
21 September 2018
Pharmaceutical industry

EPO Upholds Gilead Patent On Hep C Medicines, But In Amended Form

Editor's pick
Intellectual Property Watch
16 September 2018
Pharmaceutical industry

Groups Call for End to Gilead’s Unwarranted Hepatitis C Drug Monopoly in Europe

Editor's pick
MSF press release
11 September 2018
Hepatitis C treatment

South Africa: Almost half of injecting drug users surveyed have contracted Hepatitis C

Editor's pick
Bhekisisa
15 August 2018
Hepatitis C treatment

Fewer Australians are dying from hepatitis C, but thousands are still missing out on treatment

Editor's pick
ABC News
13 August 2018
Hepatitis C treatment

Fighting hepatitis C demands more than cheap drugs

Editor's pick
SciDev.Net
30 July 2018
Hepatitis C treatment

Supervised drug consumption sites offer opportunities for HCV testing and treatment

News
27 July 2018
People who inject drugs

France: the changing characteristics of people living with HIV on hepatitis C treatment

Editor's pick
AVERT
17 July 2018
Hepatitis C treatment

Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV

Editor's pick
Eurekalert Inf Dis
10 July 2018
Hepatitis C treatment

State Prisons Fail To Offer Cure To 144000 Inmates With Deadly Hepatitis C

Editor's pick
Kaiser Health News
9 July 2018
Hepatitis & HIV

Coinfection Connection

Editor's pick
POZ
27 June 2018
Access to healthcare

MSF challenges Gilead's undeserved patent in China on lifesaving hepatitis C medicine

Editor's pick
MSF press release
20 June 2018
Hepatitis C treatment

Just 12 countries worldwide on track to eliminate hepatitis C infection by 2030

Editor's pick
CDA Foundation
18 June 2018
Hepatitis C treatment

Private Payers Deny Hepatitis C Drug Coverage to 52% of Members

Editor's pick
Health Payer Intelligence
14 June 2018
Hepatitis C treatment

10 patients safely receive hepatitis C-infected lungs in new clinical trial

Editor's pick
CTV
14 June 2018
Hepatitis C treatment

EATG launches a report on access to HCV-related services in the penitentiary system in Europe

Editor's pick
EATG
23 May 2018
Hepatitis C treatment

Do direct acting antivirals cure chronic hepatitis C?

Editor's pick
BMJ
18 May 2018
Hepatitis C symptoms & diagnosis

Do fatigue and quality of life improve after hepatitis C is cured?

News
16 May 2018
Hepatitis C treatment

How states could be saving more hepatitis C patients

Editor's pick
USC News
15 May 2018
Access to healthcare

Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents

Editor's pick
Intellectual Property Watch
14 May 2018
Pharmaceutical industry

Gilead Topples As Its Hepatitis C Drug Franchise Continues To Crumble

Editor's pick
Investor's Business Daily
2 May 2018
Hepatitis C treatment

Many European countries are not ready to stop viral hepatitis

Editor's pick
Eurekalert Medicine & Health
19 April 2018
Hepatitis C treatment

Routine clinical use of DAAs highly effective and safe in people with HIV/HCV in Europe

News
19 April 2018